Archive

Board declares interim dividend of Rs 1.50 per equity share of Rs 5 each

The studies may provide the first definitive data on a Tau-based approach to disease-modifying and preventative treatment of…

Construction of new production facility to start in early 2013 and expected to be fully operational by the end of 2016

Rise in applications for pharmaceutical patents is a good omen for the Indian pharma industry. However, lack of patent experts to…

IDMA-GSB invites associations to discuss the issue further

To expedite research and development of new methods and technologies

Brilinta is indicated to reduce heart attack and cardiovascular death in patients with Acute Coronary Syndromes (ACS)

Kurvelo tablets are the AB-rated generic equivalent of Teva’s Nordette tablets

DIA to partner PHARMA Pro&Pack Expo 2013

Conference to be held in Mumbai on November 23, 2012